IgE-mediated reactions to rifaximin and rifamycin SV and cross-reactivity among rifamycins.
Antonicelli
L
L
SOD Allergologia, Ospedali Riuniti Ancona Via Conca - Torrette, Ancona 60126, Italy. l.antonicelli@ao-umbertoprimo.marche.it
Micucci
C
C
Bilò
M B
MB
Manfredi
M
M
Valentini
M
M
Campi
P
P
D000284:Administration, Oral; D000287:Administration, Topical; D000707:Anaphylaxis / Q000097:blood / Q000276:immunology*; D003429:Cross Reactions; D004342:Drug Hypersensitivity / Q000097:blood / Q000276:immunology*; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D012294:Rifamycins / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology*; D000078262:Rifaximin; D013530:Surgical Wound Infection / Q000188:drug therapy
D012294:Rifamycins; D007073:Immunoglobulin E; C023808:rifamycin SV; D000078262:Rifaximin